{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/698f26aed6c27a06bb5d7778?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Women in Science, Robotics, Automation, SLAS, and Lilly Updates","description":"<p>Women in Science Day (February 11) was the top of the list for discussion for GEN editors in this week’s podcast. They shared an anecdote on the history of the term “scientist”—hint it was coined for a woman. A modern scientist, Medra CEO Michelle Lee, discussed with <em>GEN</em> how the company is integrating robotics with AI for use in biological research. <em>GEN</em> attended SLAS this week and we got an update on the automation updates along with endeavors to increase the presence of women in biotech leadership. Finally, we get an update on Eli Lilly’s recent major deals followed by an update on Nektar Therapeutics clinical trial updates. </p><p>&nbsp;</p><p>&nbsp;</p><p>Join <em>GEN</em> editors Corinna Singleman, PhD, Fay Lin, PhD, Uduak Thomas and Alex Philippidis for a discussion of the latest biotech and biopharma news.&nbsp;</p><p>&nbsp;</p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base</em>:&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/topics/artificial-intelligence/data-is-a-robotics-problem-medra-ceo-says-physical-ai-will-transform-biology/\" rel=\"noopener noreferrer\" target=\"_blank\">Data Is a Robotics Problem, Medra CEO Says Physical AI Will Transform Biology</a></p><p>By Fay Lin, PhD, <em>GEN Edge</em>, February 11, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/multimedia/videos/robots-on-the-red-line-a-video-update-from-slas-2026/\" rel=\"noopener noreferrer\" target=\"_blank\">Robots on the Red Line: A Video Update from SLAS 2026</a></p><p><em>GEN</em>, February 11, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/bioprocessing/slas-highlights-ai-labs-small-molecule-spr-protein-interaction-assays-and-paper-labware/\" rel=\"noopener noreferrer\" target=\"_blank\">SLAS Highlights: AI Labs, Small-Molecule SPR, Protein Interaction Assays, and Paper Labware</a></p><p>By Uduak Thomas, <em>GEN</em>, February 11, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/cancer/slas-highlights-opening-keynote-spotlights-novel-target-in-genomically-unstable-tumors/\" rel=\"noopener noreferrer\" target=\"_blank\">SLAS Highlights: Opening Keynote Spotlights Novel Target in Genomically Unstable Tumors</a></p><p>By Uduak Thomas, <em>GEN</em>, February 11, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/news/opentrons-uses-nvidia-tech-to-build-training-data-that-powers-physical-ai-in-the-lab/\" rel=\"noopener noreferrer\" target=\"_blank\">Opentrons Uses Nvidia Tech to Build Training Data That Powers Physical AI in the Lab</a></p><p>By Uduak Thomas, <em>GEN</em>, February 9, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/translational-medicine/beyond-obesity-lilly-inks-up-to-11-25b-in-cancer-immune-system-deals/\" rel=\"noopener noreferrer\" target=\"_blank\">Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System Deals</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, February 10, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/genome-editing/lilly-seamless-ink-up-to-1-12b-hearing-loss-collaboration/\" rel=\"noopener noreferrer\" target=\"_blank\">Lilly, Seamless Ink Up-to-$1.12B Hearing Loss Collaboration</a></p><p>By Alex Philippidis, <em>GEN Edge</em>, January 28, 2026</p><p><br></p><p><a href=\"https://www.genengnews.com/category/multimedia/podcasts/touching-base/\" rel=\"noopener noreferrer\" target=\"_blank\">Touching Base Podcast</a>&nbsp;</p><p>Hosted by Corinna Singleman, PhD&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.insideprecisionmedicine.com/category/multimedia/podcasts/\" rel=\"noopener noreferrer\" target=\"_blank\">Behind the Breakthroughs</a>&nbsp;</p><p>Hosted by Jonathan D. Grinstein, PhD&nbsp;</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}